Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,864
Sort by:
Small-Molecule Targeted Cancer Therapies: World Market 2013-2023
US$ 2,400.00
... Our work shows you the commercial possibilities. Nine ways Small-Molecule Targeted Cancer Therapies: World Market 2013-2023 helps you To sum up, ... following knowledge on the topic: Forecasted revenues to 2023 for the overall world market - you discover the industry's future prospects Predicted revenues of ...
December 2012
174 pages
The Next Wave In Cancer Treatment - Kinase Inhibitors
US$ 2,500.00
This Kalorama Information report – The Next Wave in Cancer Treatment--Kinase Inhibitors - is focused on a growing area of cancer treatment, kinase inhibitors. Several ... currently marketed and late stage development kinase inhibitors for cancer treatment. Revenues for this market segment were generated using ...
December 2012
160 pages
Innovative CA Tumor Marker Tests Technologies and Emerging Markets
US$ 3,880.00
... and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for ...
November 2012
278 pages
Innovative Cancer Diagnostic Technologies and Emerging Markets
US$ 18,960.00
... market players and potential entrants; and suggests alternative business expansion strategies for suppliers. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...
November 2012
1200 pages
Analysis of Cancer Diagnostic Technologies And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...
September 2012
185 pages
US Market Changes in the Treatment of Advanced Prostate Cancer
US$ 2,900.00
Progressively unfolding patient case scenarios were presented to 151 U.S. oncologists in a survey for their open-ended responses providing rich insight into their clinical decisions. Data includes specific treatment choices, factors that influence their decisions, barriers to optimal treatment and confidence ...
September 2012
30 pages
US Market Changes in the Treatment of Advanced Melanoma
US$ 2,900.00
... regimen choices, factors that influence their decisions, barriers to optimal patient care and confidence in patient treatment. This report identifies market changes based on a comparison of physician practice patterns from 2011 and 2012 and provides actionable data for developing marketing strategies.
September 2012
31 pages
US Market Changes in the Treatment of Advanced Breast Cancer
US$ 2,900.00
... of treatment regimens, factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients. This survey was conducted in 2011 and 2012 to determine trends across time and changes in practice patterns in the management of advanced breast cancer.
September 2012
34 pages
US Market Changes in the Treatment of Advanced Lung Cancer
US$ 2,900.00
The purpose of this study is to examine changes in the market for therapeutics used in the treatment of advanced lung cancer by examining longitudinal practice patterns of oncologists. Progressively unfolding patient case scenarios were presented to 152 U.S. oncologists for their responses to open-ended ...
September 2012
39 pages
US Market Changes in the Treatment of Non-Hodgkin's Lymphoma
US$ 2,900.00
... factors that influenced their decisions, barriers to optimal patient treatment and confidence in treatment and management of patients. This survey was conducted in 2011 and 2012 using parallel cases to determine trends across time and changes in practice patterns in the management of non-Hodgkin’s lymphoma.
September 2012
46 pages
Cancer Generics Market Analysis
US$ 1,000.00
Across the globe, oncology market, one of the fastest growing segments of pharmaceutical industry, has been expanding on back of rising cancer incidences, and hefty investment by private players. Acco...
May 2012
75 pages
2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 22,800.00
... genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the ... identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next ten years; examines trends in the ...
April 2012
1200 pages
2012 France Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
585 pages
2012 Germany Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
585 pages
2012 ItalyCancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
570 pages
2012 Japan Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 5,360.00
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
April 2012
590 pages